Status:

COMPLETED

Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers

Lead Sponsor:

Hunter College of City University of New York

Conditions:

Anxiety

Eligibility:

All Genders

18-40 years

Phase:

PHASE2

Brief Summary

Computer-based attention bias modification treatment (ABMT), which is brief, cost-effective, and easy to administer, targets a key mechanism in pathological anxiety - the threat bias, or exaggerated a...

Detailed Description

Anxiety disorders are the most common psychiatric diagnosis, affecting as many as 29% of people during their lifetime. In addition to the devastating personal cost of anxiety, the yearly economic cost...

Eligibility Criteria

Inclusion

  • We will recruit ninety adults with moderate to severe symptoms of anxiety between the ages of 21 and 40, with an equal balance of males and females.

Exclusion

  • Exclusion criteria include current or past episodes of disorders that include psychotic features (e.g., mania, schizophrenia, etc.,), suicidal intent, substance dependence, changes in pharmacological treatments during the 12 weeks prior to study entry, any concurrent psychotherapy, and serious medical illness.
  • Other current and/or past Axis I diagnoses will not be excluded, but will be tracked.
  • Given high rates of co-morbidity with anxiety, depressive symptoms will also be measured to assess impact on findings.
  • To ensure understanding of the protocol, other exclusion criteria include inability to read, inability to complete assessments (i.e., severely impaired), and lack of English language comprehension.

Key Trial Info

Start Date :

February 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2018

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT02200003

Start Date

February 1 2015

End Date

July 1 2018

Last Update

August 1 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hunter College of the City University of New York

New York, New York, United States, 10065

Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers | DecenTrialz